Abacavir

Common genetic variation and the control of HIV-1 in humans

CPIC Guidelines for HLAB genotype and Abacavir dosing_Supplemental_Material

HLA-B-5701 screening for hypersensitivity to Abacavir

HLA-B-5701 screening for suscpetibility to Abacavir hypersensitivity

Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir-correlation with HLA-B-5701

Association of the genetic marker for abacavir hypersensitivity HLA-B-5701 with HCP5 rs2395029 in Mexican mestizos

CPIC Guidelines for HLAB genotype and Abacavir dosing

fda-label-abacavir

HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C allleles area attributable mainly to either HLA-A10 or HLA-B-57 alleles

HLA and pharmacogenetics of drug hypersensitivity

In Mexican mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity

Individualization of antiretroviral therapy

List of Tags SNP for HLA alleles

Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance

The HCP5 SNP- a simple screening tool for prediction of hypersensitivity reaction to abacavir

Regresar al Acervo